Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mastocytosis demystified.

Hematology. American Society of Hematology. Education Program - 8 Dec 2023

Veitch Scott, Radia Deepti H

Abstract excerpt

Mastocytosis is a rare, clinically heterogenous clonal hematological neoplasm. Over 95% of patients harbor the driver KIT D816V mutation resulting in mast cell (MC) accumulation and proliferation in various organs, leading to variable symptom manifestations that result from MC mediator release in patients with systemic mastocytosis (SM) and end-organ damage in those with advanced SM. The accurate diagnostic and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Proto-Oncogene Proteins c-kit
Share to Mast Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mastocytosis

Share to Mastocytosis, Systemic

Source

Open in PubMed Open full text

Identifiers

PMID: 38066855
DOI: 10.1182/hematology.2023000505
PMCID: PMC10727054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mastocytosis demystified.PMID 38066855Read ↗

Systemic mastocytosis for the practicing clinician: overview, diagnostic features, prognostication and antiproliferative treatment in the era of targeted therapy.Semantic proximity Read ↗

Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Mastocytosis.Semantic proximity Read ↗

Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis.Semantic proximity Read ↗

Diagnosis, progression patterns and prognostication in mastocytosis.Semantic proximity Read ↗

Comprehensive Mastocytosis Data Analysis From A Single CenterSemantic proximity Read ↗

Mastocytosis: state of the art.Semantic proximity Read ↗

How we diagnose and treat systemic mastocytosis in adults.Semantic proximity Read ↗

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.Semantic proximity Read ↗

Diagnosis and management of mastocytosis: an emerging challenge in applied hematology.Semantic proximity Read ↗

Mastocytosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.